Joke Snoeck

1.3k total citations
20 papers, 663 citations indexed

About

Joke Snoeck is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Joke Snoeck has authored 20 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 14 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Joke Snoeck's work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (7 papers). Joke Snoeck is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (7 papers). Joke Snoeck collaborates with scholars based in Belgium, Switzerland and France. Joke Snoeck's co-authors include Anne–Mieke Vandamme, Amalio Telenti, Kristel Van Laethem, Nadia Rahm, Inge Derdelinckx, Grégoire Vuagniaux, Christine Chable-Bessia, Bijan Sobhian, Monsef Benkirane and Daniel Sauter and has published in prestigious journals such as PLoS ONE, Journal of Virology and Cell Host & Microbe.

In The Last Decade

Joke Snoeck

20 papers receiving 653 citations

Peers

Countries citing papers authored by Joke Snoeck

Since Specialization

Citations

This map shows the geographic impact of Joke Snoeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joke Snoeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joke Snoeck more than expected).

Fields of papers citing papers by Joke Snoeck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joke Snoeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joke Snoeck. The network helps show where Joke Snoeck may publish in the future.

Co-authorship network of co-authors of Joke Snoeck

This figure shows the co-authorship network connecting the top 25 collaborators of Joke Snoeck. A scholar is included among the top collaborators of Joke Snoeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joke Snoeck. Joke Snoeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HCV1b genome evolution under selective pressure of the cyclophilin inhibitor alisporivir during the DEB-025-HCV-203 phase II clinical trial 2016 ·Infection Genetics and Evolution ·Lize Cuypers, Joke Snoeck, (unknown), Pieter Libin, R. Crabbé, Sonia Van Dooren, Grégoire Vuagniaux, Anne–Mieke Vandamme	3
2	A near-full length genotypic assay for HCV1b 2014 ·Journal of Virological Methods ·Lize Cuypers, Joke Snoeck, Bram Vrancken, (unknown), Grégoire Vuagniaux, Jannick Verbeeck, Frederik Nevens, Ricardo Camacho, Anne–Mieke Vandamme, Sonia Van Dooren	10
3	Susceptibility and adaptation to human TRIM5α alleles at positive selected sites in HIV-1 capsid 2013 ·Virology ·Nadia Rahm, David Gfeller, Joke Snoeck, Raquel Martínez, Paul J. McLaren, Millán Ortiz, Angela Ciuffi, Amalio Telenti	8
4	Evolutionary and Functional Analyses of the Interaction between the Myeloid Restriction Factor SAMHD1 and the Lentiviral Vpx Protein 2012 ·Cell Host & Microbe ·Nadine Laguette, Nadia Rahm, Bijan Sobhian, Christine Chable-Bessia, Jan Münch, Joke Snoeck, Daniel Sauter, William M. Switzer, Walid Heneine, Frank Kirchhoff, Frédéric Delsuc, Amalio Telenti, Monsef Benkirane	144
5	Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints 2011 ·Retrovirology ·Joke Snoeck, Jacques Fellay, István Bartha, Daniel C. Douek, Amalio Telenti	41
6	ALISPORIVIR - A HOST-TARGETING ANTIVIRAL, PROVIDES LOW VIRAL BREAKTHROUGH RATE AND HIGH BARRIER TO RESISTANCE IN HCV GENOTYPE 1 TREATMENT-NAiVE PATIENTS IN THE PHASE IIB ESSENTIAL STUDY 2011 ·Bing Li, Joke Snoeck, Yanhua Tang, Christopher T. Jones, Choi-Lai Tiong-Yip, Weibin Bao, Jing Yu, Anne–Mieke Vandamme, Grégoire Vuagniaux, R. Crabbé, (unknown), (unknown), Kai‐Hsin Lin	10
7	Unique Spectrum of Activity of Prosimian TRIM5α against Exogenous and Endogenous Retroviruses 2011 ·Journal of Virology ·Nadia Rahm, Melvyn W. Yap, Joke Snoeck, Vincent Zoete, Miguel Muñoz, Ute Radespiel, Elke Zimmermann, Olivier Michielin, Jonathan P. Stoye, Angela Ciuffi, Amalio Telenti	22
8	DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A 2010 ·PLoS ONE ·Lotte Coelmont, Xavier Hanoulle, Udayan Chatterji, Carola Berger, Joke Snoeck, Michael Bobardt, Precious Lim, Inge Vliegen, Jan Paeshuyse, Grégoire Vuagniaux, Anne–Mieke Vandamme, Ralf Bartenschlager, Philippe Gallay, Guy Lippens, Johan Neyts	143
9	Impact of Genetic Variation of HIV-1 on Drug Resistance Development 2007 ·Future Virology ·Joke Snoeck, Anne–Mieke Vandamme, Ricardo Camacho	1
10	Genotypic drug resistance interpretation algorithms display high levels of discordance when applied to non-B strains from HIV-1 naive and treated patients 2006 ·FEMS Immunology & Medical Microbiology ·Laurence Vergne, Joke Snoeck, Avelin F. Aghokeng, Bart Maes, Diane Valéa, Éric Delaporte, Anne–Mieke Vandamme, Martine Peeters, Kristel Van Laethem	38
11	Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G (vol 20, pg 1789, 2006) 2006 ·Ana Abecasis, Koen Deforche, Joke Snoeck, Lee T. Bacheler, Paula McKenna, A.P. Carvalho, Perpétua Gómes, Ricardo Camacho, Anne–Mieke Vandamme	1
12	Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000–2004 2006 ·Virus Research ·(unknown), (unknown), Katja Seme, Anne–Mieke Vandamme, Joke Snoeck, Janez Tomažič, Ludvik Vidmar, (unknown), Mario Poljak	32
13	Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G 2006 ·AIDS ·Ana Abecasis, Koen Deforche, Joke Snoeck, Lee T. Bacheler, Paula McKenna, A.P. Carvalho, Perpétua Gómes, Ricardo Camacho, Anne–Mieke Vandamme	3
14	Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G 2005 ·AIDS ·Ana Abecasis, Koen Deforche, Joke Snoeck, Lee T. Bacheler, Paula McKenna, A.P. Carvalho, Perpétua Gómes, Ricardo Camacho, Anne–Mieke Vandamme	67
15	Rising Prevalence of HIV-1 Non-B Subtypes in Belgium: 1983???2001 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Joke Snoeck, Kristel Van Laethem, Philippe Hermans, Eric Van Wijngaerden, Inge Derdelinckx, Yoeri Schrooten, David van de Vijver, (unknown), Nathan Clumeck, Anne–Mieke Vandamme	44
16	Performance of ViroSeq HIV-1 Genotyping System in routine practice at a Belgian clinical laboratory 2004 ·Journal of Virological Methods ·Bart Maes, Yoeri Schrooten, Joke Snoeck, Inge Derdelinckx, Marc Van Ranst, Anne–Mieke Vandamme, Kristel Van Laethem	20
17	Influence of subtype and treatment on genetic profiles of HIV-1 reverse transcriptase and protease: do they act independently in predicting position-specific mutation probabilities in non-subtype B sequences? 2002 ·Antiviral Therapy ·Rami Kantor, David Katzenstein, Matthew J. Gonzales, Sunee Sirivichayakul, Patricia Cane, Candice Pillay, Joke Snoeck, Zehava Grossman, Anne–Mieke Vandamme, (unknown), Deenan Pillay, Praphan Phanuphak, (unknown), (unknown)	1
18	Prevalence and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999 2002 ·Virus Research ·Joke Snoeck, Sonia Van Dooren, Kristel Van Laethem, Inge Derdelinckx, Eric Van Wijngaerden, Erik De Clercq, Anne–Mieke Vandamme	37
19	Evaluation of Two Commercial Kits for the Detection of Genotypic Drug Resistance on a Panel of HIV Type 1 Subtypes A Through J 2001 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), Chiara Riva, Martine Peeters, Jean‐Claude Schmit, Éric Delaporte, Kristel Van Laethem, Kristien Van Vaerenbergh, Joke Snoeck, (unknown), Erik De Clercq, Marc Van Ranst, Anne–Mieke Vandamme	34
20	Evaluation of Two Commercial Kits for the Detection of Genotypic Drug Resistance on a Panel of HIV Type 1 Subtypes A Through J 2001 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), Chiara Riva, Martine Peeters, Jean-Claude Schmit, Éric Delaporte, Kristel Van Laethem, Kristien Van Vaerenbergh, Joke Snoeck, (unknown), Erik De Clercq, Marc Van Ranst, Anne–Mieke Vandamme	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact